Quantify Technology Holdings Limited

Quantify Technology Holdings


Quantify Technology Holdings (ASX: QFY) is developing a truly unique solution to manage home energy usage.

A lot of labour has gone into its cutting edge Internet of Things (IoT) energy saving technology. Its proprietary ‘Q Device’, along with its Fabric Extension fascias and technology offer a truly revolutionary way to manage home energy usage.

Simply, they lighten the load of lighting your home.

QFY has just signed an agreement with retail giant Harvey Norman’s largest franchisee (HNCD) to promote and sell its IoT products.

The deal could see HNCD sell in the vicinity of $20-$30 million worth of the company’s products to commercial and residential development projects; a key market QFY has had its sights on for some time.

The company has been busy in recent months, updating its management team with experienced industry experts, completing the development stage of its passive infra-red motion sensor fascia, showcasing its products to large overseas markets, and signing supply deals.

QFY’s overheads have significantly reduced it now that its products are moving into the production stages, and with its promotional opportunities are falling into place… this is looking like a very good position to be in.

The information on this page should not be the only trigger for your investment decision. Click on the links below for a more in-depth and informed examination of the company. We strongly recommend you seek professional financial advice whenever making financial investment decisions.

As it stands, the company is confident about securing more partnership and collaboration agreements in the coming months, which should significantly bolster its commercialisation pipeline.

QFY expect to deliver its product to the East Fremantle Town Hall, Lindfield Apartment development and other leading Australia projects in the second quarter of 2018.

That means we could be set to see a lot more news flow coming from this small cap in the next few months.

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free